In an effort to optimize market and customer reach, Actelion has expanded and enhanced its commercial infrastructure and capabilities. At the end of 2009, the company had expanded to 958 sales, marketing and medical professionals based in 28 Actelion country organizations and reaching an additional 36 markets through partner arrangements. This global reach, means that Actelion is fully equipped to optimize returns from current opportunities, as well as launch and commercialize future assets.
Our commercial operations are aligned to:
- Focus on all of Actelion’s opportunities and create accountability close to the customer.
- Allow scalability, from both organizational and managerial perspectives to be able to manage growth flexibly.
- Ensure an efficient and effective interaction across functions and with partners.
Business Strategy & Operations has highly experienced people with a proven track record in both specialty and GP markets to compete in an increasingly complex business environment. Together the group is now well placed to not only drive commercial excellence and leverage our unrivalled leadership in pulmonary arterial hypertension and orphan drug expertise, but also lead transformational growth initiatives and shape markets and medical utility for the potential which lies ahead.
